Ustekinumab may be more effective than anti-tumor necrosis factor (anti-TNF) therapies in achieving clinical remission among patients with Crohn-like disease of the pouch (CLDP), according to study ...

The FDA has accepted for review the sNDA for deucravacitinib for the treatment of adults with active psoriatic arthritis.

There was an increase in use of neuraxial anesthesia and peripheral nerve block analgesia rather than general anesthesia for hip fracture procedures.

From 2016 to 2022, 5.3% of all US emergency department visits were related to low back pain, with opioid administration and prescription decreasing during this same time period.

The Trump administration’s immigration policies are having negative effects on health care, impacting patients and health ...

Ustekinumab is more efficacious than vedolizumab or anti-TNFs as second- or third-line biologic therapy for perianal Crohn disease.

Osteoporosis treatment was associated with reduced hospitalization and mortality risks following fragility fracture after 80 years of age.

Hydroxychloroquine exposure during the first trimester of pregnancy was associated with a lower risk for preeclampsia among women with SLE.

The US Food and Drug Administration has announced a plan to revoke 52 food standards after concluding they are "obsolete and unnecessary." ...

Between the years 2010 and 2019, the percentage of publicly insured children with a mental health or neurodevelopmental diagnosis increased.

Patients with BS are associated with disrupted sleep quality that appears to be driven by active disease status and comorbid fibromyalgia.

The frequency of MRI-detected inflammation was similar among patients with arthralgia or inflammatory arthritis following ICI exposure.